Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy.
Keven JiHunter KellermanJess C MaceTimothy L SmithKara Y DetwillerShyam R JoshiMathew GeltzeilerPublished in: International forum of allergy & rhinology (2024)
Draf 3 surgery in CRSwNP was associated with significant improvement in SNOT-22 score at 24 months. Furthermore, only 14.9% of patients required dupilumab rescue. Patients with AERD were more likely to require rescue with dupilumab even though 75.1% avoided treatment with the biologic over the study period.